Posted by ABMN Staff on Mar 2nd, 2024
Stock analysts at StockNews.com assumed coverage on shares of M.D.C. (NYSE:MDC – Get Free Report) in a report released on Saturday. The firm set a “hold” rating on the construction company’s stock.
MDC has been the subject of a number of other research reports. Evercore ISI downgraded shares of M.D.C. from an “outperform” rating to an “in-line” rating and boosted their price objective for the company from $57.00 to $63.00 in a research report on Wednesday, January 31st. Raymond James reissued a “market perform” rating on shares of M.D.C. in a research note on Wednesday, February 7th. One analyst has rated the stock with a sell rating and five have given a hold rating to the stock. Based on data from MarketBeat, M.D.C. currently has an average rating of “Hold” and a consensus target price of $52.13.
Get Our Latest Research Report on M.D.C.
M.D.C. Price Performance
MDC opened at $62.70 on Friday. The company has a 50-day moving average of $59.62 and a 200-day moving average of $49.44. The company has a market capitalization of $4.68 billion, a P/E ratio of 11.88 and a beta of 1.55. M.D.C. has a 1-year low of $34.79 and a 1-year high of $63.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 3.92 and a current ratio of 9.76.
M.D.C. (NYSE:MDC – Get Free Report) last released its earnings results on Tuesday, January 30th. The construction company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the firm earned $1.08 EPS. The company’s revenue was down 11.9% on a year-over-year basis. Equities analysts expect that M.D.C. will post 5.38 EPS for the current fiscal year.
Institutional Trading of M.D.C.
A number of institutional investors have recently made changes to their positions in the stock. American International Group Inc. lifted its stake in shares of M.D.C. by 1.1% in the 4th quarter. American International Group Inc. now owns 32,638 shares of the construction company’s stock worth $1,803,000 after acquiring an additional 363 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of M.D.C. by 3.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 48,803 shares of the construction company’s stock worth $2,697,000 after acquiring an additional 1,799 shares during the period. GSA Capital Partners LLP acquired a new stake in shares of M.D.C. in the 4th quarter worth approximately $463,000. Mercer Global Advisors Inc. ADV lifted its stake in shares of M.D.C. by 60.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,074 shares of the construction company’s stock worth $943,000 after acquiring an additional 6,458 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of M.D.C. by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 7,043,852 shares of the construction company’s stock worth $389,173,000 after acquiring an additional 59,151 shares during the period. 88.08% of the stock is owned by institutional investors and hedge funds.
M.D.C. Company Profile
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Featured Articles
- Five stocks we like better than M.D.C.
- Consumer Discretionary Stocks Explained
- How to Buy Bitcoin Stock: 3 Easy Ways to Do It
- The How And Why of Investing in Oil Stocks
- Snowflake Stock Plunges, Don’t be Fooled, Bargain Alert
- 3 Small Caps With Big Return Potential
- Block Stock Just Hit the Recovery Rally Button
Receive News & Ratings for M.D.C. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for M.D.C. and related companies with MarketBeat.com’s FREE daily email newsletter.
You might be interested in:
